REVEALING THE SCIENTIFIC TRUTH ABOUT YOUR CANCER:
Genomic Diagnostic Tests: Since the mapping of the human genome, about 14 years ago, these new tests can now accurately identify targeted cancer treatments. They enable a move away from one size fits all assembly line cancer medicine – still common in hospitals in AU & NZ.
Monitoring & Measuring Success: Genomics can also be used to monitor if the target treatments are working effectively.
AND: Genomic diagnostic tests can be greatly augmented by pharmacogenomic tests, a blend of pharmacy & genomics.
Nutrition: These tests determine whether the patient can metabolise (digest/absorb) the identified treatment successfully. The tests can also determine your ability to metabolise certain botanicals & nutritionals. You can then be sure these will complement your medical treatments.
The new tests have revolutionised cancer medicine. The result? Better outcomes with minimal side effects.
Patients now have a choice between the outdated (used in hospitals) & new cancer technologies… What will you do?
No more guesswork.
Our patient outcomes have improved greatly due to the new genomic, pharmacogenomic & DNA tests.
IN BRIEF – WE REFER PATIENTS FOR TESTS THAT CAN…
*Determine target treatments.
*Indicate ability to metabolise treatments.
*Determine tolerance to chemotherapy or radiation treatment.
*Determine tolerance to drug based immune therapies.
*Identify optimal nutrition plans.
*Indicate best exercise for genetic type.
*Determine suitability for cannabinoid therapies.
*Monitor presence of cancer, (3 months before scans will show the cancer)
These formidable new tests lay the foundation for precision medicine, (personalised or targeted medicine). Targeted treatments generally have better outcomes and fewer side effects. The tests enable the age of minimally invasive cancer treatments & form the basis for our 5-point survivorship care plan.
Patients enrolled in our Cancer Navigation Packages are referred to world certified genomic diagnostic tests ensuring an accurate diagnosis & identification of target treatments
In the better USA hospitals, Genomic Diagnostics replace the outdated one size fits all model. No more guesswork
However; one size fits all approaches are still common in…
*Our hospitals – AU & NZ: This is the Gold Standard of Cancer Care. Hospitals are limited by finances, pharmaceutical companies, politics & insurance protocols.
*Supplements, super-foods or extreme diet approaches erroneously assume patients are genetically the same & can all metabolise essential ingredients & constituents similarly.
*Generic advice from Dr Google, family, friends, workmates is by nature, one size fits all, and may do more harm than good, can even cause or accelerate cancer.
Genome Mag – understanding the outdated one size fits all approach:
“Most often today, your treatment plan isn’t about you specifically. It’s what doctors would give to anyone with the same condition — your neighbour, the hot dog vendor, or the prime minister of Bangladesh. Most cancer medicine revolves around “standards of care,” that is providing the best courses of prevention or treatment for the average person on the street.
With breast cancer, for example, those standards mean self-exams and mammograms after a set age and the usual chemotherapy, surgery to treat a tumour if one is found.If the first treatment doesn’t work, doctors and patients move on to the next one and the next. It’s trial and error, with life on the line.
But each cancer in each person has its own genetic makeup – each tumour is a unique character with unique tendencies and vulnerabilities. In some cases, the current standard of care may be the safest, most sensible option, but it’s also one size fits all.
Sometimes that’s sufficient, but not always.” Genome Mag
Australian & New Zealand Cancer Patients are missing out on a second chance at life compared to other OECD countries